WallStSmart
IMRN

Immuron Ltd ADR

NASDAQ: IMRN · HEALTHCARE · BIOTECHNOLOGY

$0.82
+1.86% today

Updated 2026-04-30

Market cap
$7.11M
P/E ratio
P/S ratio
0.95x
EPS (TTM)
$-0.53
Dividend yield
52W range
$1 – $2
Volume
0.0M

Immuron Ltd ADR (IMRN) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-2.81M$-2.99M$-2.07M$-2.07M$-2.26M$-1.97M$-2.46M$-2.05M$-2.65M$-3.02M$-3.75M$-7.03M$-3.50M$-1.29M$-3.16M$-3.05M$-3.13M$-2.49M$-5.88M$-6.14M
Capital expenditures$62321.00$17967.00$14414.00$4890.00$0.00$18197.00$2861.00$7200.00$15901.00$3168.00$1778.00$5696.00$6594.00$1468.00$864.00$4941.00$10048.00$7739.00$195.00$0.00
Depreciation
Stock-based comp$57986.00$351620.00$16042.00$2.08M$522665.00$242950.00$1.34M$-533912.00$2.12M$94891.00$226954.00$304243.00
Free cash flow$-2.87M$-3.01M$-2.09M$-2.08M$-2.26M$-1.99M$-2.47M$-2.05M$-2.67M$-3.02M$-3.76M$-7.04M$-3.51M$-1.29M$-3.17M$-3.05M$-3.14M$-2.50M$-5.88M$-6.14M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$0.00$0.00$0.00$0.00$0.00